However, bioinformatics analysis showed that CDC73 mRNA expression is higher in gastric, lung, breast, and ovarian cancer than in normal tissues, and positive correlations were reported between CDC73 mRNA expression and overall and progression-free survival rates in gastric cancer, but that negative correlations were observed in lung, breast, and ovarian cancer [27]. This evidence concerns the gene CDC73 and ovarian carcinoma.